Remove 2001 Remove Conditions Remove Treatment
article thumbnail

There’s A Petition Underway In The UK To Get Parliament To “Reschedule psilocybin for medical research on untreatable conditions” 96K Signatures Still Needed

Cannabis Law Report

Petition: Reschedule psilocybin for medical research on untreatable conditions. Antidepressant use in England has doubled over the last decade and 1 in every 10 pounds spent by the NHS is for mental health treatments. There have been no significant developments since SSRI antidepressants were developed more than 50 years ago.

article thumbnail

Mets Owner Steve Cohen Donates $5 Million in Support of Psychedelics Research

Veriheal

The donation was made through the Steven & Alexandra Cohen Foundation —an organization founded by the hedge fund billionaire in 2001 to promote philanthropy and community service. If the FDA approves the application, it will pave the way for integrating psychedelic treatment into mainstream medical health care.

Therapy 95
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Terpene Spotlight: Pulegone

FloridaMarijuana.net

Edition (2001): Medicinal plants contain a variety of bioactive compounds such as terpenes, which are composed of essential oils. As with all medicinal interventions, terpenes and strains may affect each person and medical condition differently. According to P.M. Dewick in Medicinal Natural Products: A Biosynthetic Approach.

Terpenes 172
article thumbnail

Serbian Patients Face Jail as Medical Marijuana Legalisation Stalls. so far 20 have gone to jail

Cannabis Law Report

Balkan Insight is reporting… eople with long-term illnesses are still being given prison sentences in Serbia for using cannabis to treat medical conditions, as the government has been stalling on legal reform while vowing even harsher anti-drug enforcement. I tried standard medicine, but there wasn’t much of a result.

Patients 105
article thumbnail

SciSparc Announces Positive Topline Results For Proprietary Pain Management Compound In Pre-Clinical Study

Cannabis Law Report

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug. ” About The Study.

article thumbnail

Study: CBD “Promising” Therapy for Cocaine Addiction

CannaMD

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. Conditioned place preference.

Therapy 98
article thumbnail

UK – BMJ Report: ” Medical cannabis: patients turn to private clinics because of NHS void”

Cannabis Law Report

They offer to treat patients for pain, cancer, and gastrointestinal, neurological, and psychiatric conditions. But why are these patients being left to seek treatment from the private sector? They have also created registries to collect evidence on outcomes, drug efficacy, and adverse events.